Report Detail

Pharma & Healthcare Global Active Pharmaceutical Ingredients Market Insights, Forecast to 2025

  • RnM2814980
  • |
  • 14 May, 2019
  • |
  • Global
  • |
  • 117 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

The Active Pharmaceutical Ingredient (API) is the part of any drug that produces its effects. Some drugs, such as combination therapies, have multiple active ingredients to treat different symptoms or act in different ways.
Production of APIs has traditionally been done by the pharmaceutical companies themselves in their home countries. But in recent years many corporations have opted to send manufacturing overseas to cut costs.
This has caused significant changes to how these drugs are regulated, with more rigorous guidelines and inspections put into place.

The global Active Pharmaceutical Ingredients market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Active Pharmaceutical Ingredients market based on company, product type, end user and key regions.

This report studies the global market size of Active Pharmaceutical Ingredients in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Active Pharmaceutical Ingredients in these regions.
This research report categorizes the global Active Pharmaceutical Ingredients market by top players/brands, region, type and end user. This report also studies the global Active Pharmaceutical Ingredients market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Merck
Novartis
Pfizer
Roche
Sun Pharmaceutical Industries
Teva Pharmaceutical Industries
Abbott Laboratories
Emcure Pharmaceuticals
Ipca Laboratories
Johnson Matthey
Guilin Pharmaceutical
Johnson & Johnson
Lonza Group

Market size by Product
Synthetic
Biotech
Market size by End User
Diagnostic Laboratories
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Active Pharmaceutical Ingredients market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Active Pharmaceutical Ingredients market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Active Pharmaceutical Ingredients companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Active Pharmaceutical Ingredients submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Active Pharmaceutical Ingredients are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Active Pharmaceutical Ingredients market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Study Coverage

    • 1.1 Active Pharmaceutical Ingredients Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Active Pharmaceutical Ingredients Market Size Growth Rate by Product
      • 1.4.2 Synthetic
      • 1.4.3 Biotech
    • 1.5 Market by End User
      • 1.5.1 Global Active Pharmaceutical Ingredients Market Size Growth Rate by End User
      • 1.5.2 Diagnostic Laboratories
      • 1.5.3 Research & Academic Laboratories
      • 1.5.4 Pharmaceutical & Biotechnology Companies
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Active Pharmaceutical Ingredients Market Size
      • 2.1.1 Global Active Pharmaceutical Ingredients Revenue 2014-2025
      • 2.1.2 Global Active Pharmaceutical Ingredients Sales 2014-2025
    • 2.2 Active Pharmaceutical Ingredients Growth Rate by Regions
      • 2.2.1 Global Active Pharmaceutical Ingredients Sales by Regions
      • 2.2.2 Global Active Pharmaceutical Ingredients Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Active Pharmaceutical Ingredients Sales by Manufacturers
      • 3.1.1 Active Pharmaceutical Ingredients Sales by Manufacturers
      • 3.1.2 Active Pharmaceutical Ingredients Sales Market Share by Manufacturers
      • 3.1.3 Global Active Pharmaceutical Ingredients Market Concentration Ratio (CR5 and HHI)
    • 3.2 Active Pharmaceutical Ingredients Revenue by Manufacturers
      • 3.2.1 Active Pharmaceutical Ingredients Revenue by Manufacturers (2014-2019)
      • 3.2.2 Active Pharmaceutical Ingredients Revenue Share by Manufacturers (2014-2019)
    • 3.3 Active Pharmaceutical Ingredients Price by Manufacturers
    • 3.4 Active Pharmaceutical Ingredients Manufacturing Base Distribution, Product Types
      • 3.4.1 Active Pharmaceutical Ingredients Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Active Pharmaceutical Ingredients Product Type
      • 3.4.3 Date of International Manufacturers Enter into Active Pharmaceutical Ingredients Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Active Pharmaceutical Ingredients Sales by Product
    • 4.2 Global Active Pharmaceutical Ingredients Revenue by Product
    • 4.3 Active Pharmaceutical Ingredients Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Active Pharmaceutical Ingredients Breakdown Data by End User

    6 North America

    • 6.1 North America Active Pharmaceutical Ingredients by Countries
      • 6.1.1 North America Active Pharmaceutical Ingredients Sales by Countries
      • 6.1.2 North America Active Pharmaceutical Ingredients Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Active Pharmaceutical Ingredients by Product
    • 6.3 North America Active Pharmaceutical Ingredients by End User

    7 Europe

    • 7.1 Europe Active Pharmaceutical Ingredients by Countries
      • 7.1.1 Europe Active Pharmaceutical Ingredients Sales by Countries
      • 7.1.2 Europe Active Pharmaceutical Ingredients Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Active Pharmaceutical Ingredients by Product
    • 7.3 Europe Active Pharmaceutical Ingredients by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Active Pharmaceutical Ingredients by Countries
      • 8.1.1 Asia Pacific Active Pharmaceutical Ingredients Sales by Countries
      • 8.1.2 Asia Pacific Active Pharmaceutical Ingredients Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Active Pharmaceutical Ingredients by Product
    • 8.3 Asia Pacific Active Pharmaceutical Ingredients by End User

    9 Central & South America

    • 9.1 Central & South America Active Pharmaceutical Ingredients by Countries
      • 9.1.1 Central & South America Active Pharmaceutical Ingredients Sales by Countries
      • 9.1.2 Central & South America Active Pharmaceutical Ingredients Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Active Pharmaceutical Ingredients by Product
    • 9.3 Central & South America Active Pharmaceutical Ingredients by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Active Pharmaceutical Ingredients by Countries
      • 10.1.1 Middle East and Africa Active Pharmaceutical Ingredients Sales by Countries
      • 10.1.2 Middle East and Africa Active Pharmaceutical Ingredients Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Active Pharmaceutical Ingredients by Product
    • 10.3 Middle East and Africa Active Pharmaceutical Ingredients by End User

    11 Company Profiles

    • 11.1 Merck
      • 11.1.1 Merck Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Merck Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Merck Active Pharmaceutical Ingredients Products Offered
      • 11.1.5 Merck Recent Development
    • 11.2 Novartis
      • 11.2.1 Novartis Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Novartis Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Novartis Active Pharmaceutical Ingredients Products Offered
      • 11.2.5 Novartis Recent Development
    • 11.3 Pfizer
      • 11.3.1 Pfizer Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Pfizer Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Pfizer Active Pharmaceutical Ingredients Products Offered
      • 11.3.5 Pfizer Recent Development
    • 11.4 Roche
      • 11.4.1 Roche Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Roche Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Roche Active Pharmaceutical Ingredients Products Offered
      • 11.4.5 Roche Recent Development
    • 11.5 Sun Pharmaceutical Industries
      • 11.5.1 Sun Pharmaceutical Industries Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients Products Offered
      • 11.5.5 Sun Pharmaceutical Industries Recent Development
    • 11.6 Teva Pharmaceutical Industries
      • 11.6.1 Teva Pharmaceutical Industries Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Teva Pharmaceutical Industries Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Teva Pharmaceutical Industries Active Pharmaceutical Ingredients Products Offered
      • 11.6.5 Teva Pharmaceutical Industries Recent Development
    • 11.7 Abbott Laboratories
      • 11.7.1 Abbott Laboratories Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Abbott Laboratories Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Abbott Laboratories Active Pharmaceutical Ingredients Products Offered
      • 11.7.5 Abbott Laboratories Recent Development
    • 11.8 Emcure Pharmaceuticals
      • 11.8.1 Emcure Pharmaceuticals Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Emcure Pharmaceuticals Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Emcure Pharmaceuticals Active Pharmaceutical Ingredients Products Offered
      • 11.8.5 Emcure Pharmaceuticals Recent Development
    • 11.9 Ipca Laboratories
      • 11.9.1 Ipca Laboratories Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Ipca Laboratories Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Ipca Laboratories Active Pharmaceutical Ingredients Products Offered
      • 11.9.5 Ipca Laboratories Recent Development
    • 11.10 Johnson Matthey
      • 11.10.1 Johnson Matthey Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Johnson Matthey Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Johnson Matthey Active Pharmaceutical Ingredients Products Offered
      • 11.10.5 Johnson Matthey Recent Development
    • 11.11 Guilin Pharmaceutical
    • 11.12 Johnson & Johnson
    • 11.13 Lonza Group

    12 Future Forecast

    • 12.1 Active Pharmaceutical Ingredients Market Forecast by Regions
      • 12.1.1 Global Active Pharmaceutical Ingredients Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Active Pharmaceutical Ingredients Revenue Forecast by Regions 2019-2025
    • 12.2 Active Pharmaceutical Ingredients Market Forecast by Product
      • 12.2.1 Global Active Pharmaceutical Ingredients Sales Forecast by Product 2019-2025
      • 12.2.2 Global Active Pharmaceutical Ingredients Revenue Forecast by Product 2019-2025
    • 12.3 Active Pharmaceutical Ingredients Market Forecast by End User
    • 12.4 North America Active Pharmaceutical Ingredients Forecast
    • 12.5 Europe Active Pharmaceutical Ingredients Forecast
    • 12.6 Asia Pacific Active Pharmaceutical Ingredients Forecast
    • 12.7 Central & South America Active Pharmaceutical Ingredients Forecast
    • 12.8 Middle East and Africa Active Pharmaceutical Ingredients Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Active Pharmaceutical Ingredients Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Summary:
      Get latest Market Research Reports on Active Pharmaceutical Ingredients . Industry analysis & Market Report on Active Pharmaceutical Ingredients is a syndicated market report, published as Global Active Pharmaceutical Ingredients Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Active Pharmaceutical Ingredients market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,014.70
      4,522.05
      6,029.40
      3,630.90
      5,446.35
      7,261.80
      595,491.00
      893,236.50
      1,190,982.00
      329,160.00
      493,740.00
      658,320.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report